Corporate Banner
Satellite Banner
Technology Networks Header
Wednesday, November 26, 2014
Technology Networks
 
Register | Sign in
Home Page>News

  News Archive

Adaptimmune Secures $104 Million in Series A Financing
Friday, September 26, 2014
Company will use funding to advance programmes in multiple cancer indications.

NIH Announces Network to Accelerate Medicines for Rheumatoid Arthritis and Lupus
Friday, September 26, 2014
Partnership includes support from industry and non-profits.

Monkey Antibodies Help Fight Virus
Friday, September 26, 2014
Details of monkey antibodies against chikungunya virus could help to fight the disease in humans.

Protecting the Body from Itself
Friday, September 26, 2014
Scientists advance understanding of autoimmunity with discovery of link between major immune cell types.

Airway Muscle-On-A-Chip Mimics Asthma
Wednesday, September 24, 2014
Tissue-level model of human airway musculature could pave way for patient-specific asthma treatments.

Newborns Have Stronger Immunity Than First Thought
Wednesday, September 24, 2014
A study led by King's College London demonstrates that babies may still be able to mount a strong immune defense.

Adaptimmune Named as One of “Fierce 15” Biotech Companies of 2014
Tuesday, September 23, 2014
Company has created T-cell receptors which are deployed to target NY-ESO-1.

New Research Collaborations and Additional Grant for Immunotherapy TABs
Tuesday, September 23, 2014
New research collaborations with Max Delbrück Centre for Molecular Medicine and Helmholtz Zentrum München entered.

New Approach To Arthritis Treatment
Monday, September 22, 2014
A new approach to arthritis treatment, which avoids unforeseen side-effects by delivering drugs exclusively to affected inflamed joints, has been developed by researchers at Queen Mary University of London.

<< 5 6 7 8 9 10 11 >>
Showing Results 71 - 80 of 1255
Skyscraper Banner
SELECTBIO Market Reports
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv